Log in or Sign up for Free to view tailored content for your specialty!
Pediatrics News
Top red light therapy stories of 2024 report potential, caution
Red light therapy, a relatively new treatment option, has made waves recently as studies investigate its potential for controlling myopia in children.
Top myopia stories of 2024: Latest research on slowing progression, predicting onset
This year, Healio covered several studies and updates about treatment options to slow myopia progression, including one about a model developed to predict the onset of myopia.
InfantSEE completes 172,000 vision assessments as 20-year anniversary approaches
InfantSEE, a program managed by the American Optometric Association Foundation that provides no-cost, comprehensive eye and vision care for infants, announced that it has completed 172,000 assessments since its founding in 2005.
Log in or Sign up for Free to view tailored content for your specialty!
Low-level red light therapy superior to ortho-K for myopia control at 1 year
Low-level red light therapy was superior to orthokeratology lenses at slowing myopia progression in children in the first year of treatment, though the difference was not significant in the second year, according to study results.
Study of atropine-based myopia treatment fails to meet primary efficacy endpoint
Eyenovia’s phase 3 CHAPERONE study evaluating low-dose atropine delivered via the company’s Optejet dispenser is not meeting its primary endpoint of a less than 0.50 D progression in visual acuity over 3 years, according to a press release.
Dry eye questionnaire may not be effective diagnostic tool for children
INDIANAPOLIS — Dry Eye Questionnaire-5 scores did not appear to align with ocular signs of dry eye in pediatric patients, highlighting the need for diagnostic tools tailored for children, according to a poster at Academy 2024.
VIDEO: Understand normal myopia progression, axial elongation for better control
INDIANAPOLIS — To better manage patients with myopia, optometrists must understand normal myopia progression and axial elongation, as well as trends in treatment efficacy, according to a speaker at Academy 2024.
VIDEO: CooperVision celebrates 5-year anniversary of MiSight 1 day FDA approval
INDIANAPOLIS — CooperVision hosted an event at Academy 2024 celebrating the fifth anniversary of MiSight’s FDA approval, which was marked by patient success stories and real-world efficacy data.
Ocumetra, Topcon partner to expand digital health care solutions for myopia management
Ocumetra, an optometric data analytics and software company, has partnered with Topcon Healthcare to enhance digital health care solutions for myopia management and improve eye care outcomes for children.
A plea for universal keratoconus screening for all pediatric patients
The earlier we detect keratoconus, the better our chances of preserving functional vision by stabilizing the cornea with cross-linking treatment.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read